Correction to: Nature https://doi.org/10.1038/s41586-026-10106-5 Published online 11 February 2026
In the version of the article initially published, in the source data for Extended Data Fig. 10d, the data listed for mouse #19277 (column O) were inadvertently duplicated from the mouse #19278 column (column Y). Extended Data Fig. 10d and its source data have now been corrected in the HTML and PDF versions of the article. The original and corrected panels are shown below in Fig. 1.
Explore related subjects
Discover the latest articles and news in related subjects.Author information
Authors and Affiliations
Laboratory of Molecular Oncology, Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada
Bin Li, Ming-Chao Zhong, Cristian Camilo Galindo, Jiayu Dou, Jin Qian, Zhenghai Tang, Dominique Davidson & André Veillette
Department of Medicine, University of Montréal, Montreal, Quebec, Canada
Bin Li & André Veillette
Department of Medicine, McGill University, Montreal, Quebec, Canada
Bin Li, Cristian Camilo Galindo, Jiayu Dou & André Veillette
Cancer Center, Faculty of Health Sciences, University of Macau, Macau SAR, China
MoE Frontiers Science Center for Precision Oncology, University of Macau, Macau SAR, China
Corresponding author
Correspondence to André Veillette.
Rights and permissions
About this article
Cite this article
Li, B., Zhong, MC., Galindo, C.C. et al. Author Correction: SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer. Nature (2026). https://doi.org/10.1038/s41586-026-11409-3
Version of record
DOIhttps://doi.org/10.1038/s41586-026-11409-3
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative